by chuck_ltd | 14 Feb, 2017 | Reimbursement
In mid-November 2016 the government issued directives to review the pricing and reimbursement system and the national financing system for medicinal products. The government declared that the existing system is complex and complicated and must be improved in order to...
by chuck_ltd | 30 Sep, 2016 | CHCUK News & Articles, News, Reimbursement
It is becoming more difficult to demonstrate that new treatments are cost efficient and should be included in the reimbursement scheme. A pharmaceutical company’s application to the Dental and Pharmaceutical Benefits Agency (TLV) for a pricing and reimbursement...
by chuck_ltd | 24 Mar, 2016 | CHCUK News & Articles, HTA, News, Real Word Evidence, Reimbursement
Date: 16/02/2016 Purpose of the meeting DG SANTE was invited to the EFPIA Working Group on HTA. The purpose of the meeting was to present the EU activities on HTA and to discuss the possible ways of HTA collaboration in the area of relative efficacy (REA) in view of...
by chuck_ltd | 8 Feb, 2016 | CHCUK News & Articles, News, NIS, Pragmatic Trials, Real Word Evidence, Registry, Reimbursement
February 2016 is expected to see the launch of a single market of medicines in the framework of the Eurasian Economic Union, which may be a game changer in the industry. Currently over 30 draft acts have been adopted, establishing EEU rules and principles for movement...
by chuck_ltd | 22 Dec, 2015 | CHCUK News & Articles, News, Reimbursement
This is the first in a series of articles in our Newsletters on pricing and reimbursement in the European Union. This article deals with the basic principles for pricing of medicinal products in the UK under the: voluntary scheme established by Pharmaceutical Price...